Kazia Therapeutics Ltd (NAS:KZIA)
$ 5.6601 -0.12 (-2.05%) Market Cap: 18.85 Mil Enterprise Value: 16.70 Mil PE Ratio: 0 PB Ratio: 4.23 GF Score: 39/100

Kazia Therapeutics Ltd Annual Shareholders Meeting Transcript

Nov 15, 2022 / 11:00PM GMT
Release Date Price: $6.6 (-2.93%)
James Garner
Kazia Therapeutics Limited - CEO

Ladies and gentlemen, good morning, and welcome again to the 2022 Annual General Meeting of Kazia shareholders. It's wonderful, as you've heard, to be able to do this in person once you can see some familiar faces in the room. And of course, we have a number of shareholders who've joined us online.

Really grateful for your time this morning. I'd like to just thank [Impasi] as well, our Corporate Counsel at Baker McKenzie for their very generous hospitality and hosting us this morning. It's been an eventful year for Kazia and there's a great deal for us to discuss this morning. So I want to make sure that we make efficient use of his time. I'm going to give a short presentation this morning, just about a dozen or so slides.

And I'm going to ask if I may that we save questions for the end of the presentation. Some of them may be addressed in the presentation. And at the very least, it will hopefully provide some useful background for our discussions thereafter. So a brief presentation and then as I say, if we can save the questions to the end

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot